Samaha Eli
SEC insider (Form 3/4/5 filer). CIK 0001877589. Director at Stagwell Inc (STGW) and 1 other issuer. 19 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in NEW YORK, NY.
Companies Samaha Eli has filed insider reports for
- Stagwell Inc (STGW): Director
- Theravance Biopharma, Inc. (tbph): 10% Owner
Samaha Eli
CIK: 0001877589
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Oct 1, 2026STGW
Stagwell Inc
AwardDirect2.5K shares at avg. $8.14$20K - Jul 7, 2026tbph
Theravance Biopharma, Inc.
SaleIndirect5.6K shares at avg. $17.17$96K - Jul 6, 2026tbph
Theravance Biopharma, Inc.
SaleIndirect1.4K shares at avg. $17.04$24K - Jul 1, 2026STGW
Stagwell Inc
AwardDirect2.7K shares at avg. $7.43$20K - Jul 1, 2026tbph
Theravance Biopharma, Inc.
SaleIndirect37.8K shares at avg. $17.00$643K - Jun 30, 2026tbph
Theravance Biopharma, Inc.
SaleIndirect25K shares at avg. $17.13$429K - Jun 29, 2026tbph
Theravance Biopharma, Inc.
SaleIndirect273.9K shares at avg. $17.23$4.7M - Jun 11, 2026STGW
Stagwell Inc
AwardDirect23K shares- - Apr 1, 2026STGW
Stagwell Inc
AwardDirect3.2K shares at avg. $6.29$20K - Jan 2, 2026STGW
Stagwell Inc
AwardDirect4.1K shares at avg. $4.89$20K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  STGW Stagwell Inc | Award | 2,457 | $8.14 | $20,000 | Direct |
| Jul 7, 2026 |  tbph Theravance Biopharma, Inc. | Sale | 5,564 | $17.17 | $95,541 | Indirect |
| Jul 6, 2026 | tbph Theravance Biopharma, Inc. | Sale | 1,400 | $17.04 | $23,856 | Indirect |
| Jul 1, 2026 | STGW Stagwell Inc | Award | 2,691 | $7.43 | $19,994 | Direct |
| Jul 1, 2026 | tbph Theravance Biopharma, Inc. | Sale | 37,799 | $17.00 | $642,628 | Indirect |
| Jun 30, 2026 | tbph Theravance Biopharma, Inc. | Sale | 25,027 | $17.13 | $428,788 | Indirect |
| Jun 29, 2026 | tbph Theravance Biopharma, Inc. | Sale | 273,871 | $17.23 | $4,720,139 | Indirect |
| Jun 11, 2026 | STGW Stagwell Inc | Award | 22,970 | - | $0 | Direct |
| Apr 1, 2026 | STGW Stagwell Inc | Award | 3,180 | $6.29 | $20,002 | Direct |
| Jan 2, 2026 | STGW Stagwell Inc | Award | 4,090 | $4.89 | $20,000 | Direct |
1-10 of 19 transactions